Valproic Acid-Induced Hyperammonemic Encephalopathy as a Cause of Neurologic Deterioration after Unruptured Aneurysm Surgery
- Authors
- Lee, Sangkook; Cheong, Jinhwan; Kim, Choonghyun; Kim, Jae Min
- Issue Date
- Aug-2015
- Publisher
- 대한신경외과학회
- Keywords
- Hyperammonemia; Valproic acid; Encephalopathy
- Citation
- Journal of Korean Neurosurgical Society, v.58, no.2, pp 159 - 162
- Pages
- 4
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- Journal of Korean Neurosurgical Society
- Volume
- 58
- Number
- 2
- Start Page
- 159
- End Page
- 162
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/156674
- DOI
- 10.3340/jkns.2015.58.2.159
- ISSN
- 2005-3711
1598-7876
- Abstract
- Neurological deficits after brain surgery are not uncommon, and correct and prompt differential diagnosis is essential to initiate appropriate treatment. We describe a patient suffering from loss of consciousness due to hyperammonemia, following valproic acid treatment after surgery for an unruptured cerebral aneurysm. A 57-year-old female patient underwent successful aneurysmal neck clipping to correct an unruptured aneurysm. Her postoperative course was good, and she received anti-epileptic therapy (valproic acid) and a soft diet. Within a few days the patient experienced mental deterioration. Her serum valproic acid reached toxic levels (149.40 mg/L), and serum ammonia was fifteen times the upper normal limit (553 mmol/L; normal range, 9-33 mmol/L). After discontinuation of valproic acid and with conservative treatment, the patient recovered without any complications. Valproate-induced hyperammonemic encephalopathy is an unusual but serious neurosurgical complication, and should not be disregarded as a possible cause of neurological deficits after neurovascular surgery. Early diagnosis is crucial, as discontinuation of valproic acid therapy can prevent serious complications, including death.
- Files in This Item
-
- Appears in
Collections - 서울 의과대학 > 서울 신경외과학교실 > 1. Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.